“Access to reproductive healthcare is critical for maternal health outcomes,” Kenneth Fink, MD, the Hawaii state director of health, said in the release. “Limiting the availability of an FDA-approved medication with 20 years of usage disregards science and threatens public health. We have taken proactive steps to reduce disruption to women being able to access this safe medication in Hawaii.”
Purchasing the bulk supply in partnership with the Kapiolani Medical Center for Women and Children”ensures consistent access to care for patients across the state,” Douglas Kwock, MD, the vice president of medical affairs at Hawaii Pacific Health said in the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
